We describe the survivorship of the Exeter femoral component in a District General Hospital. Between 1994 and 1996, 230 Exeter Universal cemented femoral components were implanted in 215 patients who were reviewed at a mean of 11.2 years (10 to 13). We used one acetabular implant, the Elite Ogee component, in 218 of the 230 hips.
The first Exeter Hip implant (Howmedica International Ltd, London, United Kingdom) was used clinically in 1970. 1 It had the unique design of a collarless, double-tapered, polished femoral stem. The surface of the femoral component was changed between 1976 and 1985 to a matt surface, but this showed inferior results, 2, 3 resulting in a return to the polished surface in 1986. The Exeter Universal femoral component (Howmedica International Ltd) was introduced in 1988 and incorporated modularity, stiffening of the shoulder by the addition of metal, and a more tapered stem in the anteroposterior configuration, which was extended to the base of the neck (Fig. 1) .
The long-term results with the original design have been good, 1 and the originating centre has reported excellent results for the modified component 4 at a mean follow-up of 8.9 years, using a variety of different acetabular components. A teaching hospital has recently presented similar results 5 with a mean follow-up of 12.7 years. Again, several different acetabular components were used. The Swedish hip registry 6 has also reported good results for the Exeter Universal femoral component, although only in the last five years has it been able to distinguish between failure of the femoral and acetabular components.
Our aim was to examine the results of the use of the Exeter Universal femoral component in a District General Hospital, where the operations were performed by various grades of surgeon, with a minimum follow-up of ten years. We also aimed to establish the outcome of the combination of the Exeter femoral component and the Elite Ogee acetabular component (DePuy International Ltd, Leeds, United Kingdom), which was used in most of the patients in our series.
Patients and Methods
Between March 1994, when the Exeter total hip replacement (THR) was first used at this hospital, and December 1996, we performed 230 consecutive primary THRs, using the Exeter Universal femoral component. These were undertaken in 215 patients, six of whom underwent simultaneous bilateral THR and nine staged bilateral THR. The operations were performed by two consultants in 154 hips (67.0%), their registrars in 46 hips (20.0%), staff grade surgeons in 24 hips (10.4%) and junior trainees under varying levels of supervision in six hips (2.6%).
Of the 230 THRs, 142 were performed in women. The mean age of the patients at the time of operation was 68.9 years (44 to 89).
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The age distribution is shown in Table I . The mean weight was 71.5 kg (41 to 114), the mean height was 166.0 cm (124 to 195), and the mean body mass index was 25.8 (15.8 to 39.4) . No patient was excluded. The pre-operative diagnoses of the hips are listed in Table II . Operative technique. We used the Exeter Universal femoral component with a 26 mm diameter stainless steel head in 228 patients (99%) and 28 mm in the remainder. In 218 hips (94.8%) an Elite Ogee acetabular component was used. The uncemented Universal Biomet acetabular component (Biomet UK Ltd, Bridgend, United Kingdom) was used in the other 12 hips for clinical reasons including young and high demand patients. CMW cement (CMW Laboratories Dentsply, Exeter, United Kingdom) was used in 228 hips and Palacos cement (Schering-Plough Ltd, Welwyn Garden City, United Kingdom) in the remaining two.
In all, 228 THRs were implanted using the posterior approach and two using the direct lateral approach. The acetabulum was prepared by removing the osteophytes from the acetabular margin followed by the use of sequential hemispherical reamers to enlarge the cavity before creating multiple key-holes and using high-pressure lavage. The Elite Ogee components were cemented in place using standard viscosity CMW 1 cement with gentamicin, which was pressurised using a swab in a glove. Femoral preparation was carried out using sequential broaches, curettage, non-pressurised lavage and drying. A Hardinge cement restrictor (Corin, Cirencester, United Kingdom) was inserted 16 cm distal to the tip of the greater trochanter. Low-viscosity (CMW 3) cement was mixed in an open bowl, and inserted retrogradely using a disposable cement syringe and second-generation cementing techniques. In two THRs Palacos cement with gentamicin was used for both the femoral and acetabular components although the reasons for this preference were not documented.
All the initial clinical and operative details were collected prospectively and recorded on a database. Clinical evaluation was by a modified Harris Hip score (HHS).
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Radiological analysis. Radiography was performed postoperatively and at the five-and ten-year review. All the radiographs were examined independently by the three authors using recognised assessment techniques as recommended by Johnston et al 8 and more recent studies which have made comparisons with previous studies on the Exeter femoral component. The cementing technique was assessed using the grading of Barrack, Mulroy and Harris 9 in the zones of Gruen, McNeice and Amstutz. 10 Alignment was assessed directly from the films, and subsidence of 0.1 mm using the greater trochanter, the proximolateral cement mantle and the prosthesis as landmarks. 5 Radiolucent lines were analysed according to the definition of Kobayashi et al. 11 Proximomedial resorption and remodelling of the femur were assessed using the criteria described by Engh, Bobyn and Glassman 12 which were originally applied to uncemented prostheses. The radiographs were also examined for diaphyseal cortical hypertrophy, fractures of the cement mantle, calcar resorption and cystic changes. Heterotopic ossification was assessed using the grading of Brooker et al. 13 The acetabular component was examined for demarcation around the cement mantle as described by DeLee and Charnley.
14 The uncemented acetabular components were Statistical analysis was undertaken by GraphPad Prism version 5.0 software (GraphPad Software Inc., San Diego, California), and 95% confidence intervals (CI) were calculated using the Greenwood method.
Results
Of the 215 patients (230 hips), 76 (79 hips) had died at ten years, giving a mortality of 35%, which is lower than that of comparable studies. 4, 5 Two patients died within the acute post-operative period, one from a pulmonary embolus 14 days after surgery and one from myocardial infarction 12 days post-operatively. In the remaining patients the cause of death was thought to be unrelated to the surgery. The deceased patients' records were examined along with their most recent radiographs, and none was found to have undergone a revision of either component since their last follow-up appointment. Of the remaining 139 patients (151 hips), 121 (121 hips) attended for radiological follow-up. The others had either moved away or were too infirm to attend. Those who were unable to attend for radiography were either sent a postal questionnaire or contacted by telephone. None had undergone any revision surgery, which was also verified by their general practitioner. Only one patient, who failed to attend for follow-up from six months after operation, has been lost to follow-up.
The mean follow-up of the surviving patients was 11.2 years (10 to 13). Pre-operatively, the mean modified HHS for pain was 5.2 (0 to 40) and the mean function score was 14.7 (10 to 44). At ten years the mean modified HHS for pain was 38.2 (0 to 44) and mean function score was 34.1 (8 to 47). There is no physical examination component to the modified HHS so this could not be analysed. The two patients who reported pain scores ≤ 10 at review had multiple medical co-morbidities, but no concomitant radiological changes. Of the 17 patients with pain scores ≤ 20, three had femoral components which had been inserted in > 3° of varus, and one had diaphyseal hypertrophy; none of these changes was progressive. No other corresponding radiological changes were identified to explain the low scores. Most patients had common medical co-morbidities associated with advancing age such as dementia or being bed-ridden and, therefore, found it difficult to answer the questions. Radiological findings. At a minimum follow-up of ten years, 121 paired anteroposterior and lateral radiographs were available for review. The assessment of cementing showed that 60 hips were in Barrack grade A, 53 in grade B and eight in grade C. A total of 79 hips (65.3%) was inserted within 2° of varus or valgus, with no significantly different change in alignment over ten years. Subsidence up to 3 mm at the cement-prosthesis interface was noted in all hips with an apparent relationship between subsidence and Barrack grading which did not reach statistical significance. Grade A hips appeared to subside less than grade C hips. No migration at the cement-bone interface was observed in any case. A fracture of the cement mantle was seen in one hip with no apparent history of trauma. The radiological findings were not progressive and the patient did not report any concern about worsening pain or diminishing function.
Radiolucent lines were seen in 15 hips (12.4%), but these did not exceed more than 40% of the cement-bone interface in any hip. Progressive lines were seen in two hips within the first five years of surgery but then stabilised at between five and ten years.
Resorptive bone remodelling changes with rounding off at the proximal femoral neck combined with the loss of medial cortical density extending to the level of the lesser trochanter (grade 2) were noted in ten hips with the remainder being grade 0 or grade 1. Distal cortical hypertrophy was noted in 14 hips (11.6%), ten of which were found to have grade-B or grade-C cementation (Fig. 2) . Femoral (Fig. 3) ; with revision of the Elite Ogee acetabular component for aseptic loosening as an endpoint the survival was 97.1% (Fig. 4) and the worst case scenario with revision for any reason to include the patient lost to follow-up showed survival of 96.6% at 13 years (Fig. 5 ).
Discussion
Our study is the first to show the findings at a minimum follow-up of ten years for the Exeter Universal femoral component in a District General Hospital. It is also the first to demonstrate a successful combination of this femoral component with the Elite Ogee acetabular component which was used in all but six of the THRs. No femoral component required revision for loosening, giving comparable results with those of the originating centre 4 and those from a teaching unit, 5 but with a longer mean follow-up. Unlike these earlier studies, we did lose one patient to follow-up, but even considering the worst-case scenario with revision of the THR for any reason the survival was 94.4% (Fig. 5) . Graph showing survivorship curve showing the worst case scenario with revision for any cause as the endpoint.
The femoral component was shown to have few radiolucent lines at the cement-bone interface, confirming the observation by the Bristol group 5 who also used secondgeneration cementing techniques. All the femoral components in our series were found to subside to an extent, which seemed to be linked to the Barrack grading. In our series, of those available for radiological review, 42 hips (34.7%) were inserted in more than 2° of varus or valgus. Historically, malposition of the femoral component has been considered to be detrimental to outcome with a reported increase in the risk of femoral fracture and aseptic loosening. 17 However, the Exeter femoral component has been shown to subside into valgus and internal rotation because of the rounded shoulder of the implant, 18 but the taper-slip principle depends on subsidence to ensure stability. 19 Our results support the conclusion of the Bristol group 5 that although the cementing technique does have a bearing on the behaviour of the stem the design is very tolerant of a less-than-perfect cement mantle.
Only one femoral component had a non-progressive fracture of the cement mantle, which was similar to previous studies. 4, 5 Cortical hypertrophy was seen in 14 of 121 hips, which is a slightly higher rate than has been previously published. 4, 5 The extent of the hypertrophy was minor in all cases but seemed to reflect the Barrack cement grading. However, this was not matched to poor outcome, diminished function or unsatisfactory pain scores. We had no cases of femoral osteolysis which agreed with the Exeter series, 4 but contrasted with the Bristol group, 5 in which most poor results could be attributed to the use of a variety of acetabular components with high rates of wear.
Despite using CMW cement in 228 hips, for which the Swedish hip registry reports a risk ratio for aseptic loosening of 0.73, 20 which is higher than that of other commonly-used bone cements, there was no increase in the rate of aseptic loosening of the femoral component compared with the Exeter and Bristol groups, who used Simplex and Palacos cement with risk ratios of 0.60 and 0.51, respectively. The Exeter femoral component has even performed favourably in comparison with other components such as the Charnley component when paired with Boneloc cement which has a risk ratio of 1.0 at five years. 21, 22 This further supports the contention that the design of the Exeter femoral component allows for migration without affecting its inherent stability or longevity.
Our results appear to agree with those of Fender, van der Meulen and Gregg 23 who found no difference in outcome between consultant and trainee surgeons with the Charnley THR. However, another report identified considerably more revisions when comparing trainees with consultants undertaking cemented THR. 24 Nevertheless our series concerns the first 230 Exeter THRs performed in this hospital, suggesting that the outcome is not dependent on the experience of the surgeon.
The Elite Ogee acetabular component was used in 218 (94.8%) of the THRs undertaken in our study. The National Joint Registry reports this to be the second most commonly used cemented acetabular component in England and Wales in 2007. 25 The Exeter femoral component and Ogee component were found to be the most common combination of components matched from different manufacturers; the Swedish hip registry 6 shows a survival of 98.9% at five years for this combination. Our survivorship for the Elite Ogee component was 97.1% at a mean follow-up of 11.2 years. Although 59% of the acetabular components had one or more lucent areas in the zones described by DeLee and Charnley, 14 no acetabular component had migrated and there were no areas of focal pelvic osteolysis seen in the 121 radiographs analysed. The survivorship for this component with the Charnley femoral component has been reported as 97% and 100%. 26, 27 Together, our results and those from the Swedish hip registry 6 suggest that the Exeter femoral component and Elite Ogee acetabular component are a good combination.
When the database from which our data were extracted was established in 1994 it did not incorporate a rigorous collection of all post-operative complications which might not result in a revision of the implant. Some data were collected on dislocations, thromboembolic events and other medical complications, but these were not sufficiently robust for critical analysis. The database and patient questionnaire have since been altered to collect this information. Additionally, it should be noted that the modified HHS used throughout has been modified since it did not include the component of the patient's examination. Because of a lack of funding initially it was not possible to recall each patient for an annual examination to complete the modified HHS. As an alternative, postal or telephone enquiries were carried out. We accept that the lack of complete scores is a limitation of our study and prevents comparison with the findings of other publications.
Our results, produced from a District General Hospital with a mixture of grades of operating surgeon, are excellent and compare with those of the originating centre at a minimum follow-up of ten years. We have also demonstrated that the combination with the Ogee acetabular component is successful and, together, these components produce a reliable THR which can be used both by experienced and trainee surgeons.
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